Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Shan Zhou, Fang-Ling Zhao, Shuang-Hu Wang, Yi-Ran Wang, Yun Hong, Quan Zhou, Pei-Wu Geng, Qing-Feng Luo, Jian-Ping Cai & Da-Peng Dai. (2023) Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo. Pharmaceutical Biology 61:1, pages 356-361.
Read now
Read now
Jinliang Xie, Dingwei Liu, Jianxiang Peng, Shuang Wu, Dongsheng Liu & Yong Xie. (2023) Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline. Expert Review of Anti-infective Therapy 21:4, pages 447-454.
Read now
Read now
Yun Hong, Da-Peng Dai, Jian-Ping Cai, Shuang-Hu Wang, Yi-Ran Wang, Fang-Ling Zhao, Shan Zhou, Quan Zhou, Pei-Wu Geng, Yun-Fang Zhou, Xue Xu, Ji-Hua Shi & Qing-Feng Luo. (2022) Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo. Drug Design, Development and Therapy 16, pages 1779-1789.
Read now
Read now
Alfredo J Lucendo. (2022) Drug treatment strategies for eosinophilic esophagitis in adults. Expert Opinion on Pharmacotherapy 23:7, pages 827-840.
Read now
Read now
Sonsoles Tamarit-Sebastian, Francisco Miguel Ferrer-Soler & Alfredo J Lucendo. (2022) Current options and investigational drugs for the treatment of eosinophilic esophagitis. Expert Opinion on Investigational Drugs 31:2, pages 193-210.
Read now
Read now
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, Maria Giulia Demarzo, Nicola de Bortoli & Edoardo Savarino. (2021) Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art. Drug Design, Development and Therapy 15, pages 1609-1621.
Read now
Read now
Feifei Chen, Hui Jiang, Jia Xu, Shuanghu Wang, Deru Meng, Peiwu Geng, Dapeng Dai, Quan Zhou & Yunfang Zhou. (2020) In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine. Drug Design, Development and Therapy 14, pages 4815-4824.
Read now
Read now
Elisa Marabotto, Sebastiano Ziola, Vincenzo Savarino, Edoardo Giovanni Giannini, Manuele Furnari, Giorgia Bodini, Fabiana Zingone, Matteo Ghisa, Brigida Barberio, Patrizia Zentilin & Edoardo Savarino. (2020) Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data. Clinical and Experimental Gastroenterology 13, pages 99-104.
Read now
Read now
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, Manuele Furnari, Giorgia Bodini, Costanza De Maria, Salvatore Tolone, Nicola De Bortoli, Marzio Frazzoni & Edoardo Savarino. (2020) Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease. Expert Review of Clinical Pharmacology 13:4, pages 437-449.
Read now
Read now
Articles from other publishers (26)
Asif Hossain Anik, Farhana Alam Proma, Pranoy Saha & Sabarni Sarker. (2024) Tegoprazan as a New Remedy for Gastrointestinal Diseases in Comparison
with its Therapeutic Predecessors: A Mini-Review. Current Drug Research Reviews 16:1, pages 11-17.
Crossref
Crossref
Yuvarajgouda N. Patil & Sharanappa T. Nandibewoor. (2024) Development of novel Ce doped ZnO/graphene based sensor for electrochemical investigation of potassium-competitive acid blocker: Vonoprazan. Materials Science in Semiconductor Processing 171, pages 108039.
Crossref
Crossref
Zinan Zhang, Fen Liu, Feiyan Ai, Xiong Chen, Rui Liu, Chao Zhang, Ning Fang, Tian Fu, Xiaoyan Wang & Anliu Tang. (2023) The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori. Frontiers in Pharmacology 14.
Crossref
Crossref
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, Manuele Furnari, Giorgia Bodini, Edoardo Giovanni Giannini & Edoardo Vincenzo Savarino. (2023) Gastrointestinal functional disorders can benefit from the use of medical devices made of substances. Frontiers in Drug Safety and Regulation 3.
Crossref
Crossref
Wen-Lin Zhang, Bo-Shen Lin, Yue-Yue Li, Yu-Ming Ding, Zhong-Xue Han & Rui Ji. (2023) Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis. Digestion 104:4, pages 249-261.
Crossref
Crossref
Yi Hu, Xin Xu, Yao‐Bin Ouyang, Cong He, Nian‐Shuang Li, Chuan Xie, Chao Peng, Zhen‐Hua Zhu, Yong Xie, Xu Shu, Nong‐Hua Lu & Yin Zhu. (2022)
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating
Helicobacter pylori
infection in China: A prospective, randomized clinical pilot study
. Helicobacter 27:4.
Crossref
Crossref
Cheol Min Shin. (2022) Acid Suppressive Drugs. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 22:2, pages 119-130.
Crossref
Crossref
Yi Hu, Xin Xu, Yao-Bin Ouyang, Cong He, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Xu Shu, Yong Xie, Nong-Hua Lu & Yin Zhu. (2022) Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Elisa MARABOTTO, Edoardo G. GIANNINI, Patrizia ZENTILIN, Sebastiano ZIOLA, Afscin DJAHANDIDEH SHEIJANI, Edoardo SAVARINO & Vincenzo SAVARINO. (2022) Pharmacotherapies in eosinophilic esophagitis: state of the art. Minerva Gastroenterology 68:1.
Crossref
Crossref
Tiaotiao Miao, Yao Zhang, Lin Bai, Xiangqian Yang & Xinli Wen. (2022) Vonoprazan vs. lansoprazole for the treatment of endoscopic submucosal dissection induced gastric ulcer: a systematic review and meta-analysis. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Carmelo Scarpignato. 2022. Gastroesophageal Reflux in Children. Gastroesophageal Reflux in Children
273
305
.
Yuko Kanbayashi, Koichi Sakaguchi, Fumiya Hongo, Takeshi Ishikawa, Yusuke Tabuchi, Osamu Ukimura, Koichi Takayama & Tetsuya Taguchi. (2021) Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis. Scientific Reports 11:1.
Crossref
Crossref
Francesco Rettura, Francesco Bronzini, Michele Campigotto, Christian Lambiase, Andrea Pancetti, Ginevra Berti, Santino Marchi, Nicola de Bortoli, Frank Zerbib, Edoardo Savarino & Massimo Bellini. (2021) Refractory Gastroesophageal Reflux Disease: A Management Update. Frontiers in Medicine 8.
Crossref
Crossref
Felice Schnoll‐Sussman & Philip O. Katz. 2021. The Esophagus. The Esophagus
428
443
.
Nao Takahashi, Kaori Ikeda, Genki Iwai, Kaori Shinbori, Hironori Baba, Takanobu Sasaki, Kuniyuki Takahashi, Yuka Morita & Arata Horii. (2021) Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs). European Archives of Oto-Rhino-Laryngology 278:5, pages 1483-1489.
Crossref
Crossref
Chun-Yan Niu & Xiao-Chun Luo. (2021) Application of potassium competitive acid blockers in acid-related diseases. World Chinese Journal of Digestology 29:8, pages 383-388.
Crossref
Crossref
Yousef Abdel‐Aziz, David C. Metz & Colin W. Howden. (2021) Review article: potassium‐competitive acid blockers for the treatment of acid‐related disorders. Alimentary Pharmacology & Therapeutics 53:7, pages 794-809.
Crossref
Crossref
Carmelo Scarpignato & Richard H. Hunt. (2021) Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers. Current Treatment Options in Gastroenterology 19:1, pages 94-132.
Crossref
Crossref
GL Muntingh. (2021) Gastro-oesophageal reflux disease: extinguishing that fire. South African General Practitioner 2:5, pages 178-183.
Crossref
Crossref
Carmelo Scarpignato, Michio Hongo, Justin C. Y. Wu, Christian Lottrup, Adriana Lazarescu, Ellen Stein & Richard H. Hunt. (2020) Pharmacologic treatment of GERD: Where we are now, and where are we going?. Annals of the New York Academy of Sciences 1482:1, pages 193-212.
Crossref
Crossref
Sabine Roman. 2020. Clinical and Basic Neurogastroenterology and Motility. Clinical and Basic Neurogastroenterology and Motility
225
236
.
Carmelo Scarpignato & Richard H. Hunt. (2019) The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. Current Opinion in Gastroenterology 35:4, pages 344-355.
Crossref
Crossref
Hyun Kang, Beom Jin KimGeunjoo Choi & Jae Gyu Kim. (2019) Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer. Medicine 98:24, pages e15860.
Crossref
Crossref
Mitsuhiro Nishihara, Hitomi Yamasaki, Richard Czerniak & Helen Jenkins. (2018) In Vitro Assessment of Potential for CYP-Inhibition-Based Drug–Drug Interaction Between Vonoprazan and Clopidogrel. European Journal of Drug Metabolism and Pharmacokinetics 44:2, pages 217-227.
Crossref
Crossref
Jennifer Nguyen-Lee, Christine T. Nguyen-Buckley & Ani Bagdasarjana. 2019. Pharmacology and Physiology for Anesthesia. Pharmacology and Physiology for Anesthesia
645
656
.
Richard H. Hunt & Carmelo Scarpignato. (2018) Potent Acid Suppression with PPIs and P-CABs: What’s New?. Current Treatment Options in Gastroenterology 16:4, pages 570-590.
Crossref
Crossref